Crossmark

Rv3737 is required for Mycobacterium tuberculosis growth in vitro and in vivo and correlates with bacterial load and disease severity in human tuberculosis

Crossref DOI link: https://doi.org/10.1186/s12879-021-06967-y

Published Online: 2022-03-14

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Qing

Peng, Zhangli

Fu, Xuefeng

Wang, Hong

Zhao, Zhaoliang

Pang, Yu

Chen, Ling
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81960004, 81760003)
License Information

Text and Data Mining valid from 2022-03-14

Version of Record valid from 2022-03-14
More Information

Article History

Received: 20 February 2021

Accepted: 7 December 2021

First Online: 14 March 2022

Declarations

:

: This study was subject to approval by the Ethics Committees of the Affiliated Hospital of Zunyi Medical University. Simultaneously, this study used data collected from patient records while maintaining patient anonymity. Because this study presented no more than minimal risk of harm to patient subjects, the Ethics Committees approved a waiver of patient informed consent. All methods were carried out in accordance with relevant guidelines and regulations.

: Not applicable.

: The authors declare no conflict of interest regarding the publication of this paper.

Document is current

Any future updates will be listed below